Fractyl Health, Inc. Debt Conversion, Converted Instrument, Amount
Fractyl Health, Inc. (GUTS) reported Debt Conversion, Converted Instrument, Amount of $19.15 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-24.
Financial Statements › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2026-03-24
- Fractyl Health, Inc. debt conversion, converted instrument, amount for the quarter ending 2024-12-31 was $0.00.
- Fractyl Health, Inc. debt conversion, converted instrument, amount for the quarter ending 2024-09-30 was $0.00.
- Fractyl Health, Inc. debt conversion, converted instrument, amount for the quarter ending 2024-06-30 was $0.00.
- Fractyl Health, Inc. debt conversion, converted instrument, amount for the quarter ending 2024-03-31 was $19.15M.
- Fractyl Health, Inc. debt conversion, converted instrument, amount for fiscal 2024 was $19.15M.
| Period end | Debt Conversion, Converted Instrument, Amount 3 month | Debt Conversion, Converted Instrument, Amount 6 month | Debt Conversion, Converted Instrument, Amount 9 month | Debt Conversion, Converted Instrument, Amount 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $0.00 derived: sum of 2 quarters · filed 2026-03-24 | $0.00 derived: sum of 3 quarters · filed 2026-03-24 | $19.15M 10-K · filed 2026-03-24 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2025-11-12 | $19.15M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $19.15M 10-Q · filed 2025-08-12 | ||
| 2024-03-31 | $19.15M 10-Q · filed 2025-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |